These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7878767)

  • 21. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
    Reinsmoen NL; Matas AJ
    Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged allogeneic and xenogeneic microchimerism in unmatched primates without immunosuppression by intrathymic implantation of CD34+ donor marrow cells.
    Allen MD; Weyhrich J; Gaur L; Akimoto H; Hall J; Dalesandro J; Sai S; Thomas R; Nelson KA; Andrews RG
    Cell Immunol; 1997 Nov; 181(2):127-38. PubMed ID: 9398400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys.
    Kawai T; Cosimi AB; Wee SL; Houser S; Andrews D; Sogawa H; Phelan J; Boskovic S; Nadazdin O; Abrahamian G; Colvin RB; Sach DH; Madsen JC
    Transplantation; 2002 Jun; 73(11):1757-64. PubMed ID: 12084998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.
    Ciancio G; Burke GW; Garcia-Morales R; Suzart K; Rosen A; Ricordi C; Kenyon NS; Mathew JM; Tzakis AG; Esquenazi V; Miller J
    Transplantation; 2002 Aug; 74(4):488-96. PubMed ID: 12352907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined simultaneous kidney/bone marrow transplantation.
    Shapiro R; Rao AS; Fontes P; Zeevi A; Jordan M; Scantlebury VP; Vivas C; Gritsch HA; Corry RJ; Egidi F
    Transplantation; 1995 Dec; 60(12):1421-5. PubMed ID: 8545868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Sachs DH; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Migratory nonparenchymal cells after organ allotransplantation: with particular reference to chimerism and the liver.
    Starzl TE; Demetris AJ; Rao AS; Thomson AW; Trucco M; Murase N
    Prog Liver Dis; 1994; 12():191-213. PubMed ID: 7746875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microchimerism, dendritic cell progenitors and transplantation tolerance.
    Thomson AW; Lu L; Murase N; Demetris AJ; Rao AS; Starzl TE
    Stem Cells; 1995 Nov; 13(6):622-39. PubMed ID: 8590864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
    Li H; Colson YL; Ildstad ST
    Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
    Cosimi AB; Sachs DH; Sykes M; Kawai T
    Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutual tolerance after liver and not after heart transplantation? Evaluation of patient-anti-donor and donor-anti-patient responses by mixed lymphocyte culture.
    van der Mast BJ; van Besouw NM; Hepkema BG; Weimar W; van de Berg AP; Slooff MJ; Claas FH
    Transpl Immunol; 1998 Mar; 6(1):33-8. PubMed ID: 9640626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.
    Mattsson J; Uzunel M; Remberger M; Tammik L; Omazic B; Levitsky V; Zou JZ; Hentschke P; Ringdén O
    Clin Exp Immunol; 2001 Jan; 123(1):162-9. PubMed ID: 11168014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells.
    Jin MX; Engelstad K; Oluwole SF
    Transplantation; 1992 Jul; 54(1):113-8. PubMed ID: 1385914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats.
    Markus PM; Selvaggi G; Cai X; Fung JJ; Starzl TE
    Cell Transplant; 1993; 2(4):345-53. PubMed ID: 8162277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.